
FDA
Recalls Cordis Balloon Catheters with Potentially
Fatal Defects
- Medical device used to open blocked blood vessels could
fail to properly function.
On this Page:
Heart Patients Risk Serious Injury or Death
Balloon catheters are used in the medical
procedure known as percutaneous transluminal
coronary angioplasty or PCTA. In
this surgical procedure, narrowed or blocked blood vessels or
arteries of the heart are “opened” using the balloon
catheter. Basically, the surgeon inserts the balloon catheter
into the blocked artery, then inflates it to clear the blockage. The
surgeon then deflates the balloon before removing it from the
artery. It is critical for the balloon to deflate completely to allow the free flow of blood to resume.
back to top
The Injuries
The defective Cordis balloon
catheters have the potential to continue to block the blood vessels
during the procedure by either failing to
deflate or deflating
too slowly. When this happens,
the patient can be injured in the following ways:
- Heart attack
- Death
- More extensive surgery
- Change in the heart rate or heart rhythm
- Injury to the coronary artery
back to top
Who may be injured?
- Heart patients who used the Cordis “Dura
Star RX” or “Fire
Star RX PTCA” balloon catheter while undergoing balloon
angioplasty in the U.S. between August 29, 2007 and January
8, 2008 (worldwide between March 26, 2007 through January 8,
2008);
- Heart patients who experienced complications during or
after a balloon angioplasty procedure using the Cordis Balloon
Catheter.
back to top
The Recalled Balloon Catheters
On January 14, 2008,
Johnson & Johnson issued a worldwide recall of its “Dura
Star RX” and “Fire
Star RX PTCA” balloon catheters made by Cordis Corporation,
a subsidiary of Johnson & Johnson.
- Approximately 57,000
of the defective devices were distributed in the United States
between August 29, 2007 and January 8, 2008.
- Worldwide,
the devices were sold from March 26, 2007 through January 8,
2008.
- All “Dura Star RX” and “Fire
Star RX” Lots
13173912 through 13315455 have been recalled.
- Also, some
52 additional lots above 13315455 are affected.
- No lots
above 13329055 are affected.
back to top
Contact the injury attorneys of Kershaw, Cutter & Ratinoff
The personal injury lawyers of Kershaw,
Cutter & Ratinoff have handled hundreds of cases involving
dangerous and defective medical devices. Recently,
KCR has litigated and settled numerous nationwide cases involving
such medical devices and products as cardiac defibrillators and
pacemakers, drug eluting stents, surgical anti-adhesion gel,
Vioxx, and the Phen-fen diet drugs. We have the specific
knowledge and experience to help our injured clients obtain fair
compensation in these complex cases.
If you, a friend or family member experienced
complications during or after a balloon angioplasty procedure
in which a recalled defective Cordis “Dura Star RX” or “Fire
Star RX PTCA”was used, you may be entitled to compensation
for medical treatment, hospitalization, lost wages, pain and
suffering, and other damages.
Please click
here for a free case evaluation.
back to top
Nationally recognized civil litigation attorneys
If
you are looking for attorneys with a proven record of success,
please call us toll-free at 888-285-3333 for
a free case evaluation. To find out more about our excellent
team of lawyers, visit our attorney
profiles.
Copyright © 2008 Kershaw, Cutter & Ratinoff LLP.
All Rights Reserved.
|
Johnson & Johnson's
Cordis Unit
Issues Recall of Balloon Catheters
The Wall Street Journal — January
25, 2008
J&J
Recalls 130,000 Balloon Catheters
AOL Money — January 25,
2008
Johnson
& Johnson
recalls Star, Dura Star balloon catheters-FDA
Reuters — January 25, 2008
Cordis balloon catheters recall
affects devices sold worldwide from March 26, 2007 through January
8, 2008:
Dura
Star RX and
Fire
Star RX devices
Lots 13173912 through 13315455
Also, some 52 additional
lots above 13315455 are affected.
FDA Recall
Statement:
Class
1 Recall: Cordis Corporation Dura Star™ RX and Fire
Star™ RX PTCA Balloon Catheters
FDA
Web site — January 14, 2008
|